AFG210

AFG210 is a potent multi-target kinase inhibitor that primarily inhibits Abl kinase (IC50=330 nM), and also has inhibitory effects on other kinases such as B-Raf, C-Raf, FGFR-1, RET and VEGF receptors. AFG210 can be used to study chronic myeloid leukemia and other diseases with abnormal activation of Abl kinase.

For research use only. We do not sell to patients.

  • CAS No.: 228400-22-4
  • Formula: C19H14F3N3O2
  • Molecular Weight:373.33
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Bcr-Abl Isoforms

More

All Raf Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00